Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia
about
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimagingCorrection: Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in ColombiaClinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine AntimoniateRisk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasisCombined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.Improving Leishmania species identification in different types of samples from cutaneous lesions.Plant-derived compounds in treatment of leishmaniasis.Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS.Spatial distribution, Leishmania species and clinical traits of Cutaneous Leishmaniasis cases in the Colombian army.Chemotherapy of leishmaniasis: present challenges.Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.Crotoxin stimulates an M1 activation profile in murine macrophages during Leishmania amazonensis infection.Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
P2860
Q27304615-9C4EC2C3-DE7D-45F0-8F4E-4B8B321EA77DQ28539887-E85994D6-E16D-4CF9-8699-B379BED9D0C7Q28552530-3924E7B0-4AEE-485C-A548-F456B956AAA8Q33570722-6A360C9F-9FB5-4E1A-B5A2-8B00BCBDD751Q33602811-371ADE75-0848-4404-B722-42D9FFF203EFQ33728704-CD4A965D-5331-4D6C-B8AC-89E9B5F26CD9Q35193291-0FD425BF-6B40-48C9-9CA4-4E0A42447BDDQ36680343-C831876C-574C-4D0E-BD8A-EFA077B9518DQ36850042-BE73D79E-20BE-4E3F-9FE1-F2EB9E1FB74BQ38603784-2818AF18-3F15-488B-8A1A-F3025B51FA4AQ39011875-B651E134-1EA0-4527-BA4D-3EB84E6300DCQ40079529-3B29D6EB-6610-4BB7-A0C5-8CD45B039506Q40161712-F7BAB204-516B-43DA-8371-9EEBFD59E280Q55210168-5A63F889-40AC-4624-BF49-C346DDB11555
P2860
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Miltefosine and antimonial dru ...... high transmission in Colombia
@ast
Miltefosine and antimonial dru ...... high transmission in Colombia
@en
Miltefosine and antimonial dru ...... high transmission in Colombia
@nl
type
label
Miltefosine and antimonial dru ...... high transmission in Colombia
@ast
Miltefosine and antimonial dru ...... high transmission in Colombia
@en
Miltefosine and antimonial dru ...... high transmission in Colombia
@nl
prefLabel
Miltefosine and antimonial dru ...... high transmission in Colombia
@ast
Miltefosine and antimonial dru ...... high transmission in Colombia
@en
Miltefosine and antimonial dru ...... high transmission in Colombia
@nl
P2093
P2860
P3181
P1476
Miltefosine and antimonial dru ...... high transmission in Colombia
@en
P2093
Clemencia Ovalle
Isabel Rodríguez
Liliana Valderrama
María Adelaida Gomez
Nancy Gore Saravia
Olga Lucía Fernández
Sandra Muvdi
Yira Diaz-Toro
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002871
P407
P577
2014-05-01T00:00:00Z